STOCK TITAN

AbCellera to Present at Upcoming Investor Conferences in March

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AbCellera (ABCL) executives to present at investor conferences, including 44th Annual TD Cowen Health Care Conference and KeyBanc Capital Markets Life Sciences & MedTech Investor Forum.
Positive
  • None.
Negative
  • None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:

  • 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, 2024, at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time)
  • KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024, at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time)

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.

About AbCellera Biologics Inc.
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Inquiries

Media: Kathleen Reid; media@abcellera.com, +1(604)724-1242

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When will AbCellera executives present at the 44th Annual TD Cowen Health Care Conference?

AbCellera executives will present at the 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, 2024, at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time).

Which investor conference will AbCellera executives attend on March 20, 2024?

AbCellera executives will attend the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024, at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time).

Where can the live audio webcasts of the presentations be accessed?

The live audio webcasts of the presentations can be accessed through links posted on AbCellera's Investor Relations website.

Will replays of the webcasts be available?

Yes, replays of each webcast will be available through the same links following the presentations.

AbCellera Biologics Inc. Common Shares

NASDAQ:ABCL

ABCL Rankings

ABCL Latest News

ABCL Stock Data

827.03M
208.65M
27.93%
39.78%
5.39%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER